Method Development and Validation for the Quantitation of the Complement Inhibitor Cp40 in Human and Cynomolgus Monkey Plasma by UPLC-ESI-MS

Cp40 is a 14-amino acid cyclic analog of the peptidic complement inhibitor compstatin that binds with sub-nanomolar affinity to complement component C3 and has already shown promise in various models of complement-related diseases. The preclinical and clinical development of this compound requires a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Chromatogr B Analyt Technol Biomed Life Sci
Autores principales: Primikyri, Alexandra, Papanastasiou, Malvina, Sarigiannis, Yiannis, Koutsogiannaki, Sophia, Reis, Edimara S., Tuplano, Joel V., Resuello, Ranillo R. G., Nilsson, Bo, Ricklin, Daniel, Lambris, John D.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5241290/
https://ncbi.nlm.nih.gov/pubmed/27992787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchromb.2016.12.004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares